4//SEC Filing
Washburn Theodore James Jr. 4
Accession 0001439222-25-000004
CIK 0001439222other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:02 PM ET
Size
8.9 KB
Accession
0001439222-25-000004
Insider Transaction Report
Form 4
Washburn Theodore James Jr.
Principal Accounting Officer
Transactions
- Exercise/Conversion
Common stock
2025-02-01+6,896→ 7,709 total - Sale
Common stock
2025-02-05$34.39/sh−2,272$78,134→ 5,437 total - Exercise/Conversion
Restricted stock units
2025-02-01−6,896→ 0 total→ Common stock (6,896 underlying)
Footnotes (3)
- [F1]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated February 1, 2023.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F3]The restricted stock units were granted on February 1, 2023. The shares underlying the restricted stock units will vest in full on February 1, 2025
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001874199
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:02 PM ET
- Size
- 8.9 KB